Nestle on Monday said it is buying Allergan’s Zenpep to expand in medical nutrition with a product for people who cannot digest food properly because their pancreas does not provide enough enzymes to break down fat, protein, and carbohydrates.
Zenpep had sales of $237 million in 2018.
“This is a significant opportunity for our business in the United States to add a complementary product to our existing range of nutrition products that support food ingestion, digestion and absorption,” said Greg Behar, head of Nestle Health Science in a statement.
By John Miller
Source: Reuters
Cargill is investing $150 million in a new plant that produces advanced biofuels from waste and residues, in an effort to further promote circular economy.
The European Parliament has voted to reject the ban on plant-based products using names typically associated with meat products, but has voted in favour of a plant-based dairy ban.
Researchers have developed a portable device that detects how much capsaicin a pepper contains with the help of a smartphone.
